Skip to main content
Caplight Logo









Aurum Biosciences Ltd

Aurum Biosciences Ltd

Private
GlasgowHealthcare & Life Scienceshttps://aurumbiosciences.com/

Last Round

Series A

Jul 11, 2026

Total Funding Raised

$5.43M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Aurum Biosciences Ltd is a clinical-stage biopharmaceutical company that develops novel oxygen carriers for use as therapeutics and diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Imaging, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

oxygen carrierperfluorocarbonischemic stroketheranosticsmetabolic imagingMRI contrast agentblood substituteGlasgow Oxygen Level DependentGOLDbiopharmaceuticalclinical-stage biotechtraumatic brain injuryspinal cord injury19F MRIdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aurum Biosciences Ltd Comparables

Compare Aurum Biosciences Ltd with similar companies based on industry and business-model similarity.

Aurum Biosciences Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prolong Pharmaceuticals, LLC
83%
NuvOx Therapeutics
80%
Fluoro2 Therapeutics
76%

Aurum Biosciences Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 11, 2026
SeedJan 24, 2024
VC RoundOct 12, 2020
SeedNov 13, 2015

Key People

Founding team and executive leadership

David Brennan

CEO Co-Founder

Founding Team

Aurum Biosciences Ltd Investors

Notable investors and investment history

Aurum Biosciences Ltd investors
InvestorRounds
InnoScot HealthVC Round, Seed
The TRICAPITAL SyndicateVC Round, Seed
Scottish National Investment BankVC Round, Seed
Scottish Investment Bank (Scottish Enterprise)VC Round, Seed
Wellcome TrustSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 11, 2026

    $13M round completed.

  • Jun 19, 2026

    Monthly visitors grew 327% MoM, reaching 3.1K.

Aurum Biosciences Ltd Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aurum Biosciences Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aurum Biosciences Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersGlasgow
Employee Range5
Year Founded2015
Last FundingJul 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?